Cargando…

1100. A Prospective Evaluation of Neurotoxicity Among Patients Receiving Dose-Optimized Cefepime or Meropenem With Concomitant Therapeutic Drug Monitoring

BACKGROUND: Cefepime (FEP) induced neurotoxicity (NT) may have serious implications for patients (pts). Retrospective studies have employed variable definitions of NT, finding renal impairment and FEP trough concentrations (Cmin) > 20 mg/L as risk factors. Prospective studies comparing antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Brandon, Kline, Ellen G, Shutter, Lori, Fong-Isariyawongse, Joanna, Urban, Alexandra, Murray, Holt, Byers, Karin, Shields, Ryan K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644903/ http://dx.doi.org/10.1093/ofid/ofab466.1294

Ejemplares similares

Cefepime-Induced Neurotoxicity
por: Saini, Tanjot, et al.
Publicado: (2021)

Cefepime Neurotoxicity in Patients with Renal Insufficiency
por: Kim, Seon-Yu, et al.
Publicado: (2012)

Cefepime-induced neurotoxicity: a systematic review
por: Payne, Lauren E., et al.
Publicado: (2017)

Characterizing Cefepime Neurotoxicity: A Systematic Review
por: Appa, Ayesha A, et al.
Publicado: (2017)

1228. Outcomes Associated with Empiric Cefepime or Meropenem for Bloodstream Infections Caused by Ceftriaxone-Resistant, Cefepime-Susceptible Escherichia coli and Klebsiella pneumoniae
por: Frescas, Brian E, et al.
Publicado: (2021)

Cefepime Neurotoxicity in a Patient With Acute Tubular Necrosis
por: Ojha, Niranjan, et al.
Publicado: (2020)

The Trend of Cefepime-Induced Neurotoxicity: A Systematic Review
por: Ajibola, Oluwafemi, et al.
Publicado: (2023)

Cefepime-induced neurotoxicity in a patient with coronary artery bypass
por: Shah, Megha, et al.
Publicado: (2016)

Cefepime induced neurotoxicity: A case series and review of the literature
por: Isitan, Cigdem, et al.
Publicado: (2017)

2172. Assessment of Cefepime Neurotoxicity in the FDA Adverse Reporting System
por: Groff, Lindsey, et al.
Publicado: (2018)

Cefepime-Induced Neurotoxicity in a 74-Year-Old Woman
por: Sharma, Samanvaya, et al.
Publicado: (2022)

1114. Exploring bactericidal activity and emergence of resistance for carbapenem-resistant Enterobacterales (CRE) with and without Klebsiella pneumoniae carbapenemase (KPC) treated with optimized meropenem (MEM) and meropenem-vaborbactam (MEV) exposures
por: Squires, Kevin M, et al.
Publicado: (2023)

2795. Cefepime Versus Meropenem for Infections Due to HECCcK-YeS-MAm Organisms with Cefepime MICs of 4-8 mCg/mL (S-DD)
por: Purdy, Andrew Scott, et al.
Publicado: (2023)

Cefepime-induced Neurotoxicity: Five Cases Reported in a Single Institution
por: Schlidt, Kevin, et al.
Publicado: (2018)

A Case of Cefepime-Induced Neurotoxicity: Renal Function Missing in Action
por: Lichak, Brooke P, et al.
Publicado: (2021)

Assessing the association between cefepime percentage free trough level and neurotoxicity
por: Zia, Aleena, et al.
Publicado: (2022)

2528. Cefepime Induced Neurotoxicity in Patients With or Without a History of Seizures
por: Baalbaki, Nadeem, et al.
Publicado: (2023)

In vitro Activity of Fosfomycin, Alone and Combined with Cefepime and Meropenem, Against Carbapenemase-Producing Gram-Negative Bacteria
por: Wiederhold, Nathan P, et al.
Publicado: (2017)

26. in Vitro selection Of enterobacter Cloacae with Cefepime, Meropenem, and Ceftazidime-avibactam Generate Diverse Resistance Mechanism
por: Castanheira, Mariana, et al.
Publicado: (2020)

1100 words you need to know
por: Bromberg, Murray, et al.
Publicado: (2018)

Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy
por: Fugate, Jennifer E, et al.
Publicado: (2013)

Prolonged Cefepime-Induced Neurotoxicity in a Patient with End-Stage Renal Disease
por: Nguyen, Dorothy Dao, et al.
Publicado: (2022)

Cefepime-Induced Neurotoxicity or Nonconvulsive Status Epilepticus (NCSE): A Controversy Revisited
por: Shebani, Zacharia, et al.
Publicado: (2023)

Is There a Significant Difference in Acute Kidney Injury Incidence Among Patients Treated with Vancomycin Combined with Cefepime or Meropenem?
por: Rutter, W Cliff, et al.
Publicado: (2017)

Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.
por: Lasarte-Monterrubio, Cristina, et al.
Publicado: (2021)

Cefepime‐induced neurotoxicity in a pediatric patient on chronic hemodialysis: a case report
por: Guzman‐Limon, Monica, et al.
Publicado: (2017)

Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert
por: Cunningham, John M., et al.
Publicado: (2020)

628. Utilizing Cefepime Therapeutic Drug Monitoring for Patients at Risk of or Exhibiting Signs of Neurotoxicity
por: Au, Joanna, et al.
Publicado: (2022)

In vitro Reducing Effect of Cloxacillin on Minimum Inhibitory Concentrations to Imipenem, Meropenem, Ceftazidime, and Cefepime in Carbapenem-resistant Pseudomonas aeruginosa Isolates
por: Pahlavanzadeh, Farahnaz, et al.
Publicado: (2020)

Correlation between Acinetobacter baumannii Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models
por: Kousovista, Rania, et al.
Publicado: (2021)

Cefepime: Cefepime-induced encephalopathy: case report
Publicado: (2022)

706. Ceftazidime-Avibactam (CZA) and Meropenem (MER) Are Synergistic and Bactericidal Against Genetically Diverse KPC-Producing Klebsiella pneumoniae (Kp)
por: Jones, Chelsea, et al.
Publicado: (2018)

Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study
por: Sipahi, Oguz Resat, et al.
Publicado: (2023)

Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime
por: Liu, Jiajun, et al.
Publicado: (2020)

Approach to Cefepime-Induced Neurotoxicity in the Setting of Chronic Kidney Disease: A Case Report and Review of Literature
por: Ruiz de Villa, Ariel, et al.
Publicado: (2022)

Cefepime-Induced Neurotoxicity in the Setting of Acute Kidney Injury: A Case Series and Discussion of Preventive Measures
por: Bausch, Severin, et al.
Publicado: (2022)

1378. Evaluation of the In vitro Activity of Meropenem-Vaborbactam Against Carbapenem-Resistant Enterobacteriaceae, Including Isolates Resistant to Ceftazidime–Avibactam
por: Wilson, William R, et al.
Publicado: (2018)

1580. Colistin Potentiates the In Vitro Activity of Meropenem–Vaborbactam (M/V) Against Some, but not All KPC-producing Klebsiella pneumoniae (KPC-Kp)
por: Jones, Chelsea E, et al.
Publicado: (2019)

In Vivo Efficacy of Humanized Exposures of Cefiderocol Compared with Cefepime (FEP) and Meropenem (MEM) against Gram-negative Bacteria in a Murine Thigh Model
por: Monogue, Marguerite, et al.
Publicado: (2017)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9er9qfb1rboqhv3g647tpe9pso